Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Effects of Elamipretide on Left Ventricular Function in Patients With Heart Failure With Reduced Ejection Fraction: The PROGRESS-HF Phase 2 Trial
Javed Butler, Muhammad Shahzeb Khan, Stefan D. Anker, et al.
Journal of Cardiac Failure (2020) Vol. 26, Iss. 5, pp. 429-437
Open Access | Times Cited: 68

Showing 1-25 of 68 citing articles:

Oxidative Stress and New Pathogenetic Mechanisms in Endothelial Dysfunction: Potential Diagnostic Biomarkers and Therapeutic Targets
Maria Giovanna Scioli, Gabriele Storti, Federico D’Amico, et al.
Journal of Clinical Medicine (2020) Vol. 9, Iss. 6, pp. 1995-1995
Open Access | Times Cited: 159
Pathophysiology and Therapeutic Approaches to Acute Decompensated Heart Failure
Joyce Njoroge, John R. Teerlink
Circulation Research (2021) Vol. 128, Iss. 10, pp. 1468-1486
Open Access | Times Cited: 135
Metabolic mechanisms in physiological and pathological cardiac hypertrophy: new paradigms and challenges
Julia Ritterhoff, Rong Tian
Nature Reviews Cardiology (2023) Vol. 20, Iss. 12, pp. 812-829
Closed Access | Times Cited: 90
Mitochondrial Dysfunction: The Hidden Player in the Pathogenesis of Atherosclerosis?
Giovanni Ciccarelli, Stefano Conte, Giovanni Cimmino, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 2, pp. 1086-1086
Open Access | Times Cited: 42
Semaglutide ameliorates cardiac remodeling in male mice by optimizing energy substrate utilization through the Creb5/NR4a1 axis
Yulan Ma, Chun‐Yan Kong, Zhen Guo, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 23
Elamipretide: A Review of Its Structure, Mechanism of Action, and Therapeutic Potential
Cheryl Tung, Fahimeh Varzideh, Emanuele Farroni, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 3, pp. 944-944
Open Access | Times Cited: 3
Mitochondrial contributions to vascular endothelial dysfunction, arterial stiffness, and cardiovascular diseases
Danielle L. Kirkman, Austin T. Robinson, Matthew J. Rossman, et al.
AJP Heart and Circulatory Physiology (2021) Vol. 320, Iss. 5, pp. H2080-H2100
Open Access | Times Cited: 86
Mitochondrial dysfunction and mitochondrial therapies in heart failure
Chennan Wu, Zhen Zhang, Weidong Zhang, et al.
Pharmacological Research (2021) Vol. 175, pp. 106038-106038
Closed Access | Times Cited: 82
Mitochondrial Dysfunction in Cardiovascular Diseases: Potential Targets for Treatment
Jiaqi Yang, Qianyun Guo, Xunxun Feng, et al.
Frontiers in Cell and Developmental Biology (2022) Vol. 10
Open Access | Times Cited: 53
Reactive Oxygen Species Induced Pathways in Heart Failure Pathogenesis and Potential Therapeutic Strategies
Aušra Mongirdienė, L Skrodenis, Leila Varoneckaitė, et al.
Biomedicines (2022) Vol. 10, Iss. 3, pp. 602-602
Open Access | Times Cited: 44
Human cardiac metabolism
Marc R. Bornstein, Rong Tian, Zoltan Arany
Cell Metabolism (2024) Vol. 36, Iss. 7, pp. 1456-1481
Closed Access | Times Cited: 15
Aging in Heart Failure
Parag Goyal, Mathew S. Maurer, Jason D. Roh
JACC Heart Failure (2024) Vol. 12, Iss. 5, pp. 795-809
Open Access | Times Cited: 11
Critical contribution of mitochondria in the development of cardiomyopathy linked to desmin mutation
Yeranuhi Hovhannisyan, Zhenlin Li, Domitille Callon, et al.
Stem Cell Research & Therapy (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 9
Systemic aging fuels heart failure: Molecular mechanisms and therapeutic avenues
Zhuyubing Fang, Umar Raza, Jia Song, et al.
ESC Heart Failure (2024)
Open Access | Times Cited: 9
Mitochondrial Dysfunction and Heart Disease: Critical Appraisal of an Overlooked Association
Giandomenico Bisaccia, Fabrizio Ricci, Sabina Gallina, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 2, pp. 614-614
Open Access | Times Cited: 52
Current and emerging drug targets in heart failure treatment
Nicolò Ghionzoli, Francesco Gentile, Annamaria Del Franco, et al.
Heart Failure Reviews (2021) Vol. 27, Iss. 4, pp. 1119-1136
Open Access | Times Cited: 43
Mitochondria as Therapeutic Targets in Heart Failure
Julia Schwemmlein, Christoph Maack, Edoardo Bertero
Current Heart Failure Reports (2022) Vol. 19, Iss. 2, pp. 27-37
Open Access | Times Cited: 33
Traditional Chinese medicine enhances myocardial metabolism during heart failure
Wang Shao-mei, Lifang Ye, Lihong Wang
Biomedicine & Pharmacotherapy (2021) Vol. 146, pp. 112538-112538
Open Access | Times Cited: 36
Redox signaling in heart failure and therapeutic implications
David Weissman, Christoph Maack
Free Radical Biology and Medicine (2021) Vol. 171, pp. 345-364
Closed Access | Times Cited: 34
SS-31, a Mitochondria-Targeting Peptide, Ameliorates Kidney Disease
Yuexin Zhu, Manyu Luo, Xue Bai, et al.
Oxidative Medicine and Cellular Longevity (2022) Vol. 2022, pp. 1-13
Open Access | Times Cited: 25
Targeting mitochondrial impairment for the treatment of cardiovascular diseases: From hypertension to ischemia-reperfusion injury, searching for new pharmacological targets
Simona Todisco, Biagia Musio, Vito Pesce, et al.
Biochemical Pharmacology (2023) Vol. 208, pp. 115405-115405
Closed Access | Times Cited: 14
Mitochondria-Targeted Drug Delivery in Cardiovascular Disease: A Long Road to Nano-Cardio Medicine
Francesca Forini, Paola Canale, Giuseppina Nicolini, et al.
Pharmaceutics (2020) Vol. 12, Iss. 11, pp. 1122-1122
Open Access | Times Cited: 38
Mitochondrial Dysfunction in Atrial Fibrillation—Mechanisms and Pharmacological Interventions
Paweł Muszyński, Tomasz A. Bonda
Journal of Clinical Medicine (2021) Vol. 10, Iss. 11, pp. 2385-2385
Open Access | Times Cited: 27
Novel Role for Cardiolipin as a Target of Therapy to Mitigate Myocardial Injury Caused by Venoarterial Extracorporeal Membrane Oxygenation
Lija Swain, Shreyas Bhave, Xiaoying Qiao, et al.
Circulation (2024) Vol. 149, Iss. 17, pp. 1341-1353
Closed Access | Times Cited: 4
Interspecies differences in mitochondria: Implications for cardiac and vascular translational research
Lisa Alibrandi, Vincenzo Lionetti
Vascular Pharmacology (2025), pp. 107476-107476
Closed Access
Page 1 - Next Page

Scroll to top